Company intelligence / Profile preview

Yunnan Tengyao Pharmaceutical

Ownership: Private
Development stage: Other

Overview

Yunnan Tengyao Pharmaceutical has one major approved product, Xinmailong Injection, which is used for chronic heart failure and is an herbal medicine.

Therapeutic areas: Cardiovascular
Modalities: Herbal medicine
Industry: Biotech

Drug pipeline

1 asset

xinmailong

Beyond the preview

Go deeper on Yunnan Tengyao Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yunnan Tengyao Pharmaceutical.